A special issue on Nursing: Current Scenario and Future Development - Articles are invited.

Effects of cholinergic system in antinociception induced by H1 and H2 receptor antagonists on somatic pain in Rats

Authors: Ali Mojtahedin

Int J Med Res Health Sci.378-383 | pdf PDF Full Text

The present study was aimed to investigate the peripheral effects of chlorpheniramine and ranitidine and their
relationship with cholinergic system on the somatic pain in rats. The somatic pain was induced by using formalin
test. The effects of H1 and H2 receptor antagonists, chlorpheniramine and ranitidine, respectively, on formalininduced
pain was studied in rats. Physostigmine and atropine were subcutaneously injected alone and also in
combination with chlorpheniramine and ranitidine. Formalin 1% produced biphasic pain response.
Chlorpheniramine and ranitidine significantly reduced the second phase of pain (p<0.05). Physostigmine at doses
0.4mg/kg significantly reduced the second phase of pain. Atropine (2 mg/kg) had no significant effect in the first and
second phases. Pre-treatment of chlorpheniramine (20mg/kg) before physostigmine (0.4mg/kg) prevented
physostigmine induced antinociception. Ranitidine (40mg/kg) before physostigmine (0.4mg/kg) significantly
suppressed the antinociceptive effects of physostigmine. Atropine before chlorpheniramine and ranitidine reversed
the analgesic effects of chlorpheniramine and ranitidine. These results indicate that physostigmine has been able to
inhibit the somatic pain through the cholinergic muscarinic receptors. Both of the histamine H1 and H2 receptor
antagonists have analgesic effects and histamine H2 but not H1 antagonist probably is involved in the analgesic
effects induced by physostigmine.

International Journal of Medical Research & Health Sciences © 2012-16 [Last updated: July 2016] by AspiringDigital